Biologics for Inflammatory Bowel Disease: Maximizing Benefits, Avoiding Complications

In Collaboration with
Overview
Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses potential complications of biologics with Dr. Gary Lichtenstein, Professor of Medicine at the Hospital of the University of Pennsylvania.
Publication Date
Release Date: 02/27/2017

0
Medical Therapy
Management of Intestinal Strictures in Crohn’s disease
Management of Intestinal Strictures in Crohn’s disease
Management of Intestinal Strictures in Crohn’s disease
- Abigail J. Meyers, PA-C
  Peer
5
Medical Therapy
Addressing Extra-Intestinal Manifestations (EIMs) in IBD
Addressing Extra-Intestinal Manifestations (EIMs) in IBD
Addressing Extra-Intestinal Manifestations (EIMs) in IBD
- Anita Afzali MD, MPH, FACG, AGAF
  Peer
- David P. Hudesman, MD
  Peer
- Ryan C. Ungaro, MD
  Peer
3
Gastroenterology and Hepatology
Current and Future Developments of Predictive Markers and Prognostic Testing in IBD
Current and Future Developments of Predictive Markers and Prognostic Testing in IBD
Current and Future Developments of Predictive Markers and Prognostic Testing in…
- Bincy P. Abraham, MD, MS
  Peer
- Jessica Allegretti, MD, MPH
  Peer
- Edouard Louis, MD, PhD
  Peer
3
Health Maintenance
De-escalation in IBD Therapy
De-escalation in IBD Therapy
De-escalation in IBD Therapy